Evidence map›Paper›PMID 42502917›Full record

ArticleChemistry, an Asian journal2026

Visible-Light-Driven Photoredox-Catalyzed Reduction of Nitro (Hetero)arenes to (Hetero)aryl Amines and Subsequent C─N Bond-Forming Reactions.

J Preety, T Purushothaman, Lekshmi Priya Sl, M Shanmugam, S Mannathan, S Karthikeyan, B Baskar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J PreetyLaboratory of Sustainable Synthesis, Department of Chemistry, SRM Institute of Science and Technology, Chengalpet, Tamil Nadu, India.
T PurushothamanLaboratory of Sustainable Synthesis, Department of Chemistry, SRM Institute of Science and Technology, Chengalpet, Tamil Nadu, India.
Lekshmi Priya SlDepartment of Chemistry, SRM Institute of Science and Technology, Chengalpet, Tamil Nadu, India.
M ShanmugamDepartment of Chemistry, SRM Institute of Science and Technology, Chengalpet, Tamil Nadu, India.
S MannathanDepartment of Chemistry, SRM University-AP, Amaravati, Andhra Pradesh, India.ORCID https://orcid.org/0000-0002-3114-8265
S KarthikeyanDepartment of Chemistry, SRM Institute of Science and Technology, Chengalpet, Tamil Nadu, India.ORCID https://orcid.org/0000-0002-3422-8009
B BaskarLaboratory of Sustainable Synthesis, Department of Chemistry, SRM Institute of Science and Technology, Chengalpet, Tamil Nadu, India.

Funding

Department of ChemistrySelective Excellence Research Initiative SERI-2021SRM Institute of Science and Technology
6 · The paper itself

Abstract

A sustainable and efficient visible-light photoredox catalytic strategy was developed for the selective reduction of nitro(hetero)arenes to the corresponding amino(hetero)arenes, followed by in situ C─N coupling, using a Cu-Ti-gCN composite as non-noble photocatalyst. The reduced products were obtained in good to excellent yields (up to 95%) under mild reaction conditions and exhibits a broad substrate scope, accommodating halogenated, heteroaromatic, and fused nitroarenes. Mechanistic studies, supported by radical-quenching experiments, indicate a multisite proton-coupled electron transfer (MS-PCET) pathway involving key radical intermediates. The application of the method was further extended to reductive cyclization reactions, providing access to biologically relevant N-heterocycles.

Indexed as

ascorbic acid/sodium ascorbate as reductantnon‐noble transition metalphotoredox catalystreduction of nitroarenesvisible light

Identifiers

PMID42502917
PMCPMC13401772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.